ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,206Medicare Part D Prescriptions Filled, Including Refills

Rank: 37 out of 2456

$886K Total Retail Price of All Prescriptions

Rank: 59 out of 2456

631 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
75% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 631 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

4% of this provider’s 631 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 16,938 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
WARFARIN SODIUM 1,163 1,142 1 9
LISINOPRIL 735 682 2 1
LEVOTHYROXINE SODIUM 720 696 3 4
FUROSEMIDE 580 564 4 8
TRAZODONE HCL 574 533 5 17
ATENOLOL 528 504 6 6
AMLODIPINE BESYLATE 441 423 7 5
SIMVASTATIN 430 405 8 2
OMEPRAZOLE 426 392 9 3
METOPROLOL TARTRATE 417 417 10 10
MIRTAZAPINE 356 341 11 29
DONEPEZIL HCL 329 329 12 23
CITALOPRAM HBR 300 288 13 14
METOPROLOL SUCCINATE 296 281 14 13
POTASSIUM CHLORIDE 292 289 15 33
LOVASTATIN 283 264 16 34
SERTRALINE HCL 270 234 17 21
GABAPENTIN 240 218 18 16
METFORMIN HCL 221 217 19 11
HYDROCHLOROTHIAZIDE 197 176 20 7
ALLOPURINOL 186 185 21 27
TAMSULOSIN HCL 184 171 22 32
NAMENDA 183 183 23 42
TRAMADOL HCL 164 148 24 24
LOSARTAN POTASSIUM 158 148 25 18
RANITIDINE HCL 157 151 26 31
QUETIAPINE FUMARATE 153 153 27 47
PRAVASTATIN SODIUM 147 119 28 15
DOXAZOSIN MESYLATE 137 126 29 71
RISPERIDONE 137 137 29 50
TORSEMIDE 123 123 31 146
LIDODERM 119 118 32 58
POLYETHYLENE GLYCOL 3350 116 108 33 64
IPRATROPIUM-ALBUTEROL 112 100 34 85
ATORVASTATIN CALCIUM 109 106 35 12
PREDNISONE 109 109 35 39
NYSTATIN 107 102 37 99
DIGOXIN 106 97 38 49
FLUTICASONE PROPIONATE 105 89 39 30
JANUVIA 103 98 40 81
ISOSORBIDE MONONITRATE ER 97 91 41 48
PANTOPRAZOLE SODIUM 95 95 42 37
TRIAMCINOLONE ACETONIDE 95 82 42 131
LEVETIRACETAM 92 75 44 90
NIFEDIPINE ER 88 83 45 61
HYDRALAZINE HCL 85 67 46 105
ZETIA 83 76 47 86
HYDROCODONE-ACETAMINOPHEN 80 36 S3 48 20
CLOPIDOGREL 78 76 49 55
FLUOXETINE HCL 78 67 49 45
ADVAIR DISKUS 77 77 51 36
LISINOPRIL-HYDROCHLOROTHIAZIDE 76 70 52 41
TRIAMTERENE-HCTZ 76 72 52 53
DIVALPROEX SODIUM 73 63 54 51
AZITHROMYCIN 72 68 55 60
LANTUS 71 62 56 44
GLIPIZIDE 71 71 56 46
NITROGLYCERIN PATCH 70 70 58 134
FINASTERIDE 69 65 59 66
SEROQUEL 65 65 60 102
NYSTOP 63 56 61 125
VENLAFAXINE HCL ER 62 60 62 92
BUSPIRONE HCL 62 61 62 157
CELEBREX 59 59 64 127
DIOVAN 59 59 64 26
SPIRONOLACTONE 57 49 66 73
CYMBALTA 56 49 67 65
METFORMIN HCL ER 54 49 68 59
CEPHALEXIN 54 54 68 153
LATANOPROST 54 54 68 156
MUPIROCIN 53 35 71 209
CARVEDILOL 53 47 71 54
KLOR-CON M20 52 52 73 69
CARBIDOPA-LEVODOPA 51 38 74 82
GLIPIZIDE ER 51 44 74 89
PROAIR HFA 50 34 76 22
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 29, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.